Defective DPM3 does not transfer mannose to DOLP to form DOLPman

Stable Identifier
R-HSA-4719354
Type
Reaction [transition]
Species
Homo sapiens
Compartment
endoplasmic reticulum membrane, cytosol, cytoplasmic side of endoplasmic reticulum membrane
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Defective DPM3 does not transfer mannose to DOLP to form DOLPman
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Dolichyl-phosphate mannosyltransferase (DPM), a heterotrimeric protein embedded in the endoplasmic reticulum membrane, mediates the transfer of mannose (from cytosolic GDP-mannose) to dolichyl phosphate (DOLP) to form dolichyl-phosphate-mannose (DOLPman). The first subunit of the heterotrimer (DPM1) appears to be the actual catalyst, and the other two subunits (DPM2 and 3) appear to stabilise it (Maeda et al. 2000). Defects in DPM3 can cause congenital disorder of glycosylation 1o (DPM3-CDG, CDG1o; MIM:612937), a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterised by under-glycosylated serum glycoproteins. CDG type 1 diseases result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency (Lefeber et al. 2009). Normally, the DPM3 subunit tethers the catalytic DPM1 subunit to the ER membrane. A homozygous 254T-C transition in the DPM3 gene results in a leu85-to-ser (L85S) substitution in a highly conserved residue in the coiled-coil domain. This mutant shows a reduced binding capacity to DPM1 which vastly reduces dolichyl-phosphate mannosyltransferase activity and therefore little or no DOLPman is formed (Lefeber et al. 2009).
Literature References
PubMed ID Title Journal Year
19576565 Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies

Ashida, H, Hess, D, Klein, D, Grünewald, S, Huyben, KM, Morava, E, Manta, P, Lammens, M, Yildiz, J, Schönberger, J, Evangeliou, A, Hofsteenge, J, Preijers, FW, Wevers, RA, Grafakou, O, van den Elzen, C, Lefeber, DJ, Verrijp, K, Maeda, Y, Guillard, M, Lehle, L, Van den Heuvel, L, Spilioti, M

Am. J. Hum. Genet. 2009
10835346 Human dolichol-phosphate-mannose synthase consists of three subunits, DPM1, DPM2 and DPM3

Kinoshita, T, Kangawa, K, Hino, J, Tanaka, S, Maeda, Y

EMBO J 2000
Participants
Input
Participates
as an event of
Catalyst Activity

dolichyl-phosphate beta-D-mannosyltransferase activity of DPM1:DPM2:DPM3 L85S [endoplasmic reticulum membrane]

Physical Entity
DPM1:DPM2:DPM3 L85S [endoplasmic reticulum membrane] (Homo sapiens)
Activity
dolichyl-phosphate beta-D-mannosyltransferase activity (GO:0004582)
Normal reaction
dolichyl phosphate + GDP-alpha-D-mannose -> dolichyl phosphate D-mannose (Homo sapiens)
Functional status

Loss of function of DPM1:DPM2:DPM3 L85S [endoplasmic reticulum membrane]

Normal Entity
Disease Entity
Status
Disease
Authored
Jassal, B  (2013-10-18)
Reviewed
Spillmann, D  (2015-04-30)
Created
Jassal, B  (2013-10-18)
Cite Us!